LONDON, Dec. 14, 2016 /PRNewswire/ -- Investigators discovered stem cells during their quest to find innovative cell therapy methods which could offer edge over prevailing modalities. These cells have ability to divide several times without losing their capability to renew again and again. This is very important because earlier, investigators believed that one type of cell is capable to giving rise to another kind of cell which means they can't change. But their discovery changed the whole scenario as a result of which several degenerative diseases could be treated. Before doing so it is imperative to classify; study and recognize their differentiation potential in clinical settings. Different types of stem cells are available due to which investigators have more choices to customize their clinical development. Their utility in cancer treatment has been noted by investigators and they have also found that it could also be used for organ repair.
Recombinant technology has improved significantly in past years due to which better therapeutics are expected to be developed in coming years. Many cancer drugs have been developed by utilization of these techniques. Cancer stem cell therapies are also expected to be developed with its help. They are expected to have superior therapeutic effects as compared to conventional therapeutics. With time, mass production is also expected to improve with improve in technology. Higher production at lower cost will allow the pharmaceutical companies to gain more market shares. They will be able to commercialize highly effective cancer stem cell therapeutics at lesser prices. In this way, they will be able to effectively compete in already overcrowded cancer therapeutics segment across the globe.
Utilization of cancer stem cells is expected to play an important role in treatment of various cancers like breast and lung cancer. Other cancers like pancreatic cancer, gastric cancer and other cancers which have been studied to lesser extent are going to have significant boost. For this, they have to identify unique features related to different cancers. Investigators are developing biochips which are expected to identify different kind of cancers. Development of this technology requires significant investments along with development of associated technology. It will allow the investigators to generate result with high confidence levels. Some time is expected to be consumed during development of these biochips.
Investigators are looking for biomolecules with therapeutic efficacy that could be used in case of cancer stem cells. Micro RNA has been identified as potential candidate which can effectively counteract the cancer stem cells. Such inhibitors are expected to have high specificity due to which lesser side effects are expected to be developed. Many properties of micro RNAs has yet to be deciphered because their side effects are not known. Concerns related to their effect on normal genes have been raised by several researchers that may hamper normal cellular activities. Most of the work has been done at laboratory levels due to which lots of time is expected to be consumed in their commercialization. Cost of these therapeutics is also a major concern as they will be out of access of several cancer patients.
Development of targeted drugs is going to play an important role in development in counteracting cancer stem cell therapy. These drugs are expected to have high specificity due to which normal cells will be spared during treatment. They will prevent the cancerous cells to develop resistance so that they won't become recalcitrant. It will also prevent the development of new cancerous cells in the body. By preventing metastasis, spread of cancer cells in different body parts would be checked. Investigators are developing drug discovery systems which would be able to find new lead molecules for developing cancer stem cell therapies. Only few candidate molecules are able to effectively eliminate cancer stem cells. As a result, significant time is consumed in the development of cancer stem cell therapies.
Download the full report: https://www.reportbuyer.com/product/4397193/
About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers
http://www.reportbuyer.com
For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]
Tel: +44 208 816 85 48
Website: www.reportbuyer.com
SOURCE ReportBuyer
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article